Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy

Details for Australian Patent Application No. 2003287078 (hide)

Owner Centelion Aventis Pharmaceuticals Inc

Inventors Soubrier, Fabienne

Agent Watermark

Pub. Number AU-B-2003287078

PCT Number PCT/US2003/0325

PCT Pub. Number WO2004/033664

Priority 10/268,948 11.10.02 US

Filing date 14 October 2003

Wipo publication date 4 May 2004

Acceptance publication date 15 January 2009

International Classifications

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/64 (2006.01) Mutation or genetic engineering - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host

C12N 15/69 (2006.01) Mutation or genetic engineering

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12R 1/01 (2006.01)

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 10/268,948 11.10.02 US

3 June 2004 Application Open to Public Inspection

  Published as AU-B-2003287078

15 January 2009 Application Accepted

  Published as AU-B-2003287078

14 May 2009 Standard Patent Sealed

20 October 2011 Alteration of Name

  The name of the patentee has been altered to Aventis Pharma S.A.; Aventis Pharmaceuticals Inc. 2005

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287079-TREATING ANDROGEN DECLINE IN AGING MALE (ADAM)-ASSOCIATED CONDITIONS WITH SARMS

2003287077-Methylene-bridged selective androgen receptor modulators and methods of use thereof